Reduction of postoperative pain

A double-blind, randomized clinical trial

William D. Browning, William W Johnson, Paul N. Gregory

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The authors investigated the capability of two commonly used basing techniques to reduce postoperative sensitivity. The authors measured the time it took the subjects to respond to a standardized stimulus of cold water (cold response measure, or CRM) at baseline and one week after treatment. The authors found no significant reduction in the mean CRM for the group receiving Amalgambond Plus (Parkell), but they did find a significant decrease in the mean CRM for the group receiving Copalite (Harry J. Bosworth Co.) with or without Vitrebond (3M). The authors concluded that the subjects in the Amalgambond Plus group experienced no more sensitivity to cold at one week postoperative than they did at baseline, while the subjects in the Copalite/Vitrebond group did.

Original languageEnglish (US)
Pages (from-to)1661-1667
Number of pages7
JournalJournal of the American Dental Association
Volume128
Issue number12
DOIs
StatePublished - Jan 1 1997

Fingerprint

Postoperative Pain
Randomized Controlled Trials
Water
Copalite
Vitrabond
Amalgambond
Therapeutics

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Reduction of postoperative pain : A double-blind, randomized clinical trial. / Browning, William D.; Johnson, William W; Gregory, Paul N.

In: Journal of the American Dental Association, Vol. 128, No. 12, 01.01.1997, p. 1661-1667.

Research output: Contribution to journalArticle

@article{0738a090132c4967bdb61f528096e881,
title = "Reduction of postoperative pain: A double-blind, randomized clinical trial",
abstract = "The authors investigated the capability of two commonly used basing techniques to reduce postoperative sensitivity. The authors measured the time it took the subjects to respond to a standardized stimulus of cold water (cold response measure, or CRM) at baseline and one week after treatment. The authors found no significant reduction in the mean CRM for the group receiving Amalgambond Plus (Parkell), but they did find a significant decrease in the mean CRM for the group receiving Copalite (Harry J. Bosworth Co.) with or without Vitrebond (3M). The authors concluded that the subjects in the Amalgambond Plus group experienced no more sensitivity to cold at one week postoperative than they did at baseline, while the subjects in the Copalite/Vitrebond group did.",
author = "Browning, {William D.} and Johnson, {William W} and Gregory, {Paul N.}",
year = "1997",
month = "1",
day = "1",
doi = "10.14219/jada.archive.1997.0128",
language = "English (US)",
volume = "128",
pages = "1661--1667",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "12",

}

TY - JOUR

T1 - Reduction of postoperative pain

T2 - A double-blind, randomized clinical trial

AU - Browning, William D.

AU - Johnson, William W

AU - Gregory, Paul N.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The authors investigated the capability of two commonly used basing techniques to reduce postoperative sensitivity. The authors measured the time it took the subjects to respond to a standardized stimulus of cold water (cold response measure, or CRM) at baseline and one week after treatment. The authors found no significant reduction in the mean CRM for the group receiving Amalgambond Plus (Parkell), but they did find a significant decrease in the mean CRM for the group receiving Copalite (Harry J. Bosworth Co.) with or without Vitrebond (3M). The authors concluded that the subjects in the Amalgambond Plus group experienced no more sensitivity to cold at one week postoperative than they did at baseline, while the subjects in the Copalite/Vitrebond group did.

AB - The authors investigated the capability of two commonly used basing techniques to reduce postoperative sensitivity. The authors measured the time it took the subjects to respond to a standardized stimulus of cold water (cold response measure, or CRM) at baseline and one week after treatment. The authors found no significant reduction in the mean CRM for the group receiving Amalgambond Plus (Parkell), but they did find a significant decrease in the mean CRM for the group receiving Copalite (Harry J. Bosworth Co.) with or without Vitrebond (3M). The authors concluded that the subjects in the Amalgambond Plus group experienced no more sensitivity to cold at one week postoperative than they did at baseline, while the subjects in the Copalite/Vitrebond group did.

UR - http://www.scopus.com/inward/record.url?scp=0031300508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031300508&partnerID=8YFLogxK

U2 - 10.14219/jada.archive.1997.0128

DO - 10.14219/jada.archive.1997.0128

M3 - Article

VL - 128

SP - 1661

EP - 1667

JO - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 12

ER -